(NASDAQ: ALRN) Aileron Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 29.46%.
Aileron Therapeutics's earnings in 2024 is -$25,221,000.On average, 2 Wall Street analysts forecast ALRN's earnings for 2024 to be -$30,548,777, with the lowest ALRN earnings forecast at -$31,848,725, and the highest ALRN earnings forecast at -$29,248,829.
In 2025, ALRN is forecast to generate -$30,332,119 in earnings, with the lowest earnings forecast at -$38,565,122 and the highest earnings forecast at -$22,099,115.